ALBO Annual Accounts Payable
$6.52 M
+$1.23 M+23.34%
31 December 2021
Summary:
As of February 5, 2025, ALBO annual accounts payable is $6.52 million, with the most recent change of +$1.23 million (+23.34%) on December 31, 2021. During the last 3 years, it has risen by +$2.16 million (+49.72%).ALBO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO Quarterly Accounts Payable
$6.95 M
+$1.56 M+28.85%
30 September 2022
Summary:
As of February 5, 2025, ALBO quarterly accounts payable is $6.95 million, with the most recent change of +$1.56 million (+28.85%) on September 30, 2022. Over the past year, it has dropped by -$272.00 thousand (-3.77%).ALBO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALBO Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.3% | -3.8% |
| 3 y3 years | +49.7% | +118.2% |
| 5 y5 years | +382.7% | +340.7% |
ALBO Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -3.8% |
Albireo Pharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $6.95 M(+28.8%) |
| June 2022 | - | $5.39 M(-15.3%) |
| Mar 2022 | - | $6.37 M(-2.3%) |
| Dec 2021 | $6.52 M(+23.3%) | $6.52 M(-9.8%) |
| Sept 2021 | - | $7.22 M(+26.6%) |
| June 2021 | - | $5.70 M(-13.3%) |
| Mar 2021 | - | $6.58 M(+24.5%) |
| Dec 2020 | $5.28 M(+10.4%) | $5.28 M(+46.7%) |
| Sept 2020 | - | $3.60 M(-23.9%) |
| June 2020 | - | $4.73 M(-30.3%) |
| Mar 2020 | - | $6.79 M(+41.9%) |
| Dec 2019 | $4.79 M(+9.9%) | $4.79 M(+50.2%) |
| Sept 2019 | - | $3.19 M(-17.0%) |
| June 2019 | - | $3.84 M(+28.5%) |
| Mar 2019 | - | $2.99 M(-31.4%) |
| Dec 2018 | $4.35 M(+222.4%) | $4.35 M(+25.0%) |
| Sept 2018 | - | $3.48 M(+15.3%) |
| June 2018 | - | $3.02 M(+34.3%) |
| Mar 2018 | - | $2.25 M(+66.5%) |
| Dec 2017 | $1.35 M(+38.9%) | $1.35 M(-14.4%) |
| Sept 2017 | - | $1.58 M(+18.7%) |
| June 2017 | - | $1.33 M(+1.5%) |
| Mar 2017 | - | $1.31 M(+772.7%) |
| Dec 2016 | $972.00 K(+548.0%) | - |
| Sept 2016 | - | $150.00 K(-67.9%) |
| Sept 2016 | $150.00 K(-64.4%) | - |
| June 2016 | - | $467.00 K(+306.1%) |
| Mar 2016 | - | $115.00 K(-65.7%) |
| Dec 2015 | - | $335.00 K(-20.4%) |
| Sept 2015 | $421.00 K(+144.8%) | $421.00 K(+122.8%) |
| June 2015 | - | $189.00 K(-45.4%) |
| Mar 2015 | - | $346.00 K(-20.5%) |
| Dec 2014 | - | $435.00 K(+152.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | $172.00 K(-30.1%) | $172.00 K(-54.0%) |
| June 2014 | - | $374.00 K(-41.7%) |
| Mar 2014 | - | $641.00 K(-64.1%) |
| Dec 2013 | - | $1.79 M(+626.8%) |
| Sept 2013 | $246.00 K(-13.7%) | $246.00 K(+2.5%) |
| June 2013 | - | $240.00 K(-23.1%) |
| Mar 2013 | - | $312.00 K(-72.4%) |
| Dec 2012 | - | $1.13 M(+296.1%) |
| Sept 2012 | $285.00 K(+28.4%) | $285.00 K(+58.3%) |
| June 2012 | - | $180.00 K(+57.9%) |
| Mar 2012 | - | $114.00 K(-24.5%) |
| Dec 2011 | - | $151.00 K(-32.0%) |
| Sept 2011 | $222.00 K(-88.8%) | $222.00 K(+117.6%) |
| June 2011 | - | $102.00 K(-55.8%) |
| Mar 2011 | - | $231.00 K(-91.8%) |
| Dec 2010 | - | $2.82 M(+41.9%) |
| Sept 2010 | $1.99 M(+97.5%) | $1.99 M(+94.8%) |
| June 2010 | - | $1.02 M(-65.0%) |
| Mar 2010 | - | $2.91 M(+80.6%) |
| Dec 2009 | - | $1.61 M(+60.2%) |
| Sept 2009 | $1.01 M(+23.9%) | $1.01 M(+268.9%) |
| June 2009 | - | $273.00 K(-55.3%) |
| Mar 2009 | - | $611.00 K(+772.9%) |
| Dec 2008 | - | $70.00 K(-91.4%) |
| Sept 2008 | $813.00 K(-62.8%) | $813.00 K(+98.8%) |
| June 2008 | - | $409.00 K(-85.8%) |
| Mar 2008 | - | $2.88 M(-32.5%) |
| Dec 2007 | - | $4.26 M(+94.7%) |
| Sept 2007 | $2.19 M(+61.2%) | $2.19 M(+32.9%) |
| June 2007 | - | $1.65 M(-4.8%) |
| Mar 2007 | - | $1.73 M(+16.7%) |
| Dec 2006 | - | $1.48 M(+9.1%) |
| Sept 2006 | $1.36 M(+2088.7%) | $1.36 M(+2088.7%) |
| Sept 2005 | $62.00 K | $62.00 K |
FAQ
- What is Albireo Pharma annual accounts payable?
- What is the all time high annual accounts payable for Albireo Pharma?
- What is Albireo Pharma annual accounts payable year-on-year change?
- What is Albireo Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Albireo Pharma?
- What is Albireo Pharma quarterly accounts payable year-on-year change?
What is Albireo Pharma annual accounts payable?
The current annual accounts payable of ALBO is $6.52 M
What is the all time high annual accounts payable for Albireo Pharma?
Albireo Pharma all-time high annual accounts payable is $6.52 M
What is Albireo Pharma annual accounts payable year-on-year change?
Over the past year, ALBO annual accounts payable has changed by +$1.23 M (+23.34%)
What is Albireo Pharma quarterly accounts payable?
The current quarterly accounts payable of ALBO is $6.95 M
What is the all time high quarterly accounts payable for Albireo Pharma?
Albireo Pharma all-time high quarterly accounts payable is $7.22 M
What is Albireo Pharma quarterly accounts payable year-on-year change?
Over the past year, ALBO quarterly accounts payable has changed by -$272.00 K (-3.77%)